In a survey of nearly 1,200 recent cancer patients and survivors conducted as part of the American Cancer Society Cancer Action Network’s Survivor Views project, more than 80% of respondents said they would be willing to use remote technologies and tools in a trial.
J. Leonard Lichtenfeld joined SpotitEarly, an Israel-based technology company transforming cancer screening by harnessing the power of artificial intelligence and dogs to detect cancer early, as chief medical officer.
